172 related articles for article (PubMed ID: 29954686)
1. Elevated serum vascular endothelial growth factor and development of cardiac allograft vasculopathy in children.
Watanabe K; Karimpour-Fard A; Michael A; Miyamoto SD; Nakano SJ
J Heart Lung Transplant; 2018 Sep; 37(9):1075-1082. PubMed ID: 29954686
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients.
Daly KP; Stack M; Eisenga MF; Keane JF; Zurakowski D; Blume ED; Briscoe DM
J Heart Lung Transplant; 2017 Apr; 36(4):434-442. PubMed ID: 27865734
[TBL] [Abstract][Full Text] [Related]
3. VEGF-C, VEGF-A and related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipients.
Daly KP; Seifert ME; Chandraker A; Zurakowski D; Nohria A; Givertz MM; Karumanchi SA; Briscoe DM
J Heart Lung Transplant; 2013 Jan; 32(1):120-8. PubMed ID: 23260712
[TBL] [Abstract][Full Text] [Related]
4. Follow-up study on the utility of von Willebrand factor levels in the diagnosis of cardiac allograft vasculopathy.
Martínez-Dolz L; Almenar L; Reganon E; Vila V; Chamorro C; Andrés L; Martínez-Sales V; Moro J; Agüero J; Sánchez-Lázaro I; Salvador A
J Heart Lung Transplant; 2008 Jul; 27(7):760-6. PubMed ID: 18582806
[TBL] [Abstract][Full Text] [Related]
5. Dual-Axis Rotational Angiography is Safe and Feasible to Detect Coronary Allograft Vasculopathy in Pediatric Heart Transplant Patients: A Single-Center Experience.
Rios R; Loomba RS; Foerster SR; Pelech AN; Gudausky TM
Pediatr Cardiol; 2016 Apr; 37(4):740-5. PubMed ID: 26846123
[TBL] [Abstract][Full Text] [Related]
6. Quantitative flow ratio computed from invasive coronary angiography as a predictor for cardiac allograft vasculopathy after cardiac transplant.
Shah H; Lee I; Rao S; Suddath W; Rodrigo M; Mohammed S; Molina E; García-Garcia HM; Kenigsberg BB
Int J Cardiovasc Imaging; 2024 Feb; 40(2):451-458. PubMed ID: 38117378
[TBL] [Abstract][Full Text] [Related]
7. Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients.
Asimacopoulos EP; Garbern JC; Gauvreau K; Blume ED; Daly KP; Singh TP
Transplantation; 2020 Jan; 104(1):e31-e37. PubMed ID: 31568274
[TBL] [Abstract][Full Text] [Related]
8. Optical Coherence Tomography for the Early Detection of Coronary Vascular Changes in Children and Adolescents After Cardiac Transplantation: Findings From the International Pediatric OCT Registry.
McGovern E; Hosking MCK; Balbacid E; Voss C; Berger F; Schubert S; Harris KC
JACC Cardiovasc Imaging; 2019 Dec; 12(12):2492-2501. PubMed ID: 30031706
[TBL] [Abstract][Full Text] [Related]
9. Cardiac allograft vasculopathy after heart transplantation: electrocardiographically gated cardiac CT angiography for assessment.
Mittal TK; Panicker MG; Mitchell AG; Banner NR
Radiology; 2013 Aug; 268(2):374-81. PubMed ID: 23657888
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphism in platelet-derived growth factor and vascular endothelial growth factor are significantly associated with cardiac allograft vasculopathy.
Tambur AR; Pamboukian S; Costanzo MR; Heroux A
J Heart Lung Transplant; 2006 Jun; 25(6):690-8. PubMed ID: 16730575
[TBL] [Abstract][Full Text] [Related]
11. Computational Analysis of Routine Biopsies Improves Diagnosis and Prediction of Cardiac Allograft Vasculopathy.
Peyster EG; Janowczyk A; Swamidoss A; Kethireddy S; Feldman MD; Margulies KB
Circulation; 2022 May; 145(21):1563-1577. PubMed ID: 35405081
[TBL] [Abstract][Full Text] [Related]
12. Surveillance for cardiac allograft vasculopathy: Practice variations among 50 pediatric heart transplant centers.
Nandi D; Chin C; Schumacher KR; Fenton M; Singh RK; Lin KY; Conway J; Cantor RS; Koehl DA; Lamour JM; Kirklin JK; Pahl E
J Heart Lung Transplant; 2020 Nov; 39(11):1260-1269. PubMed ID: 32861553
[TBL] [Abstract][Full Text] [Related]
13. PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy.
Chih S; Chong AY; Erthal F; deKemp RA; Davies RA; Stadnick E; So DY; Overgaard C; Wells G; Mielniczuk LM; Beanlands RSB
J Am Coll Cardiol; 2018 Apr; 71(13):1444-1456. PubMed ID: 29598865
[TBL] [Abstract][Full Text] [Related]
14. Early aspirin use and the development of cardiac allograft vasculopathy in pediatric heart transplant recipients: A pediatric heart transplant society analysis.
D'Addese L; Cantor RS; Koehl D; Reardon L; Ameduri R; Bock M; Morrison A; White S; Wisotzkey B; Kirklin JK; Godown J
J Heart Lung Transplant; 2023 Jan; 42(1):115-123. PubMed ID: 36328858
[TBL] [Abstract][Full Text] [Related]
15. Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients.
Kobayashi D; Du W; L'ecuyer TJ
Pediatr Transplant; 2013 Aug; 17(5):436-40. PubMed ID: 23714284
[TBL] [Abstract][Full Text] [Related]
16. Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy.
Bayliss J; Bailey M; Leet A; Stein AN; Thomson NM; McLean CA
Transplantation; 2008 Oct; 86(7):991-7. PubMed ID: 18852667
[TBL] [Abstract][Full Text] [Related]
17. Association of Endothelin-1 With Accelerated Cardiac Allograft Vasculopathy and Late Mortality Following Heart Transplantation.
Parikh RV; Khush K; Pargaonkar VS; Luikart H; Grimm D; Yu M; Okada K; Honda Y; Yeung AC; Valantine H; Fearon WF
J Card Fail; 2019 Feb; 25(2):97-104. PubMed ID: 30543947
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous coronary artery revascularization procedures in pediatric heart transplant recipients: A large single center experience.
Turner ME; Addonizio LJ; Richmond ME; Zuckerman WA; Vincent JA; Torres AJ; Collins MB
Catheter Cardiovasc Interv; 2016 Nov; 88(5):797-803. PubMed ID: 27083510
[TBL] [Abstract][Full Text] [Related]
19. Safety of optical coherence tomography in pediatric heart transplant patients.
Ulrich SM; Lehner A; Birnbaum J; Heckel S; Haas NA; Hakami L; Schramm R; Dalla Pozza R; Fischer M; Kozlik-Feldmann R
Int J Cardiol; 2017 Feb; 228():205-208. PubMed ID: 27866017
[TBL] [Abstract][Full Text] [Related]
20. Circulating monocyte chemoattractant protein-1 in heart transplant recipients with cardiac allograft vasculopathy.
Beaudeux JL; Dorent R; Bernard M; Reagan M; Foglietti MJ; Gandjbakhch I; Cacoub P
Clin Biochem; 2002 Feb; 35(1):77-9. PubMed ID: 11937083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
